Repligen (RGEN) Stock Price, Quote, News & History | Benzinga

Repligen Corp (RGEN) Stock Price, Quote, News & History

RGENNASDAQ

Trade with Public

Trade with Public

$163.90

4.462.8%

At close: Aug 7, 5:00 PM EST

$163.90

N/A

After Hours: Aug 7, 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$159.44

Close

$163.90

Volume / Avg.

950.50K / 1.22M

Day Range

$159.44 - $164.97

52 Wk Range

100.99 - 175.77

Market Cap

$9.25B

P/E Ratio

218.41

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

10.33%

Days to Cover

7.93

Recent Repligen Corporation News

Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today

A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.

Piero Cingari

Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.

Avi Kapoor

Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition

Repligen to acquire BioLife Solutions for $1.5B to boost cell therapy bioprocessing capabilities and expand global reach.

Vandana Singh

Micron Leads Memory-Stock Rally, Nasdaq 100 Tops 29,000: Stock Market Today

Semiconductors led a broad rebound Tuesday as Micron, Western Digital and Sandisk surged. Nasdaq 100 rallies past 29,000 points.

Piero Cingari

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

134.86M

Investing Cash Flow (TTM)

-222.60M

Financing Cash Flow (TTM)

-11.79M

Free Cash Flow (TTM)

110.15M

Capital Expenditure (TTM)

-24.71M

Net Change in Cash (TTM)

-99.53M

Analyst Trends and Forecast

3

Apr

3

May

2

Jun

4

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$9.13B

PE Ratio (TTM)

218.41

PE Ratio (FWD)

77.52

PEG Ratio (TTM)

2.13

PS Ratio (TTM)

11.50

PB Ratio (TTM)

4.26

Earnings Yield % (TTM)

0.46%

Earnings Yield % (FWD)

1.29%

EV / EBITDA (TTM)

51.74

Price / EBITDA (TTM)

52.62

Price / Free Cash Flow (TTM)

81.98

Book Value / Share

$37.42

Company Debt

Total Debt

$551.05M

LT Debt

$551.05M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$606.78M

Debt to Equity

0.33

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$159.44

Close

$163.90

Volume / Avg.

950.50K / 1.22M

Day Range

$159.44 - $164.97

52 Wk Range

100.99 - 175.77

Market Cap

$9.25B

P/E Ratio

218.41

Dividend Yield

-

Exchange

NASDAQ

RSI

69

Short Interest

10.33%

Days to Cover

7.93

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Repligen (RGEN) competitors?

A

Other companies in Repligen’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).

Q

What is the forecast, or price target, for Repligen (RGEN) stock?

A

Repligen has a consensus price target of $173.22.

Q

What is the current price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $163.9 last updated August 7, 2026 at 4:00 PM EDT.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen does not have any upcoming earnings scheduled.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.